Search results for "Corticotropin-Releasing Hormone"

showing 10 items of 42 documents

A Polymorphism in the Crhr1 Gene Determines Stress Vulnerability in Male Mice

2014

Chronic stress is a risk factor for psychiatric disorders but does not necessarily lead to uniform long-term effects on mental health, suggesting modulating factors such as genetic predispositions. Here we address the question whether natural genetic variations in the mouse CRH receptor 1 (Crhr1) locus modulate the effects of adolescent chronic social stress (ACSS) on long-term stress hormone dysregulation in outbred CD1 mice, which allows a better understanding of the currently reported genes × environment interactions of early trauma and CRHR1 in humans. We identified 2 main haplotype variants in the mouse Crhr1 locus that modulate the long-term effects of ACSS on basal hypothalamic-pitui…

MaleHypothalamo-Hypophyseal SystemGenotypeGene ExpressionPituitary-Adrenal SystemLocus (genetics)Single-nucleotide polymorphismRegulatory Sequences Nucleic AcidBiologyBinding CompetitivePolymorphism Single NucleotideReceptors Corticotropin-Releasing HormoneMiceEndocrinologyGene FrequencyGenetic predispositionAnimalsHumansGenetic Predisposition to DiseaseChronic stressCRHR1 GeneGeneIn Situ HybridizationSocial stressGeneticsBehavior AnimalTriazinesHaplotypeHaplotypesPituitary GlandPyrazolesFemaleGene-Environment InteractionCorticosteroneStress PsychologicalSignal TransductionEndocrinology
researchProduct

Novel sequential stress model for functional dyspepsia: Efficacy of the herbal preparation STW5

2015

Abstract Background Many screening procedures for agents with potential usefulness in functional dyspepsia (FD) rely on animals exposed to stress early in life (neonatal maternal separation, NMS) or in adulthood (restraint stress, RS). Purpose Since many clinical cases of FD have been associated with stress in early life followed by stress in adulthood, a sequential model simulating the clinical situation is described. To explore the validity of the model, the efficacy of STW5, a multicomponent herbal preparation of proven usefulness in FD, was tested. Study design/methods A sequential stress model established where rats are exposed to NMS after birth followed later by RS in adulthood. Stre…

MaleRestraint PhysicalDrugFunctional dyspepsiaPathologymedicine.medical_specialtyCorticotropin-Releasing Hormonemedia_common.quotation_subjectPharmaceutical SciencePharmacologySTW5chemistry.chemical_compoundCorticosteroneDrug DiscoverymedicineAnimalsNeonatal maternal separationDyspepsiaRats WistarScreening proceduresmedia_commonPharmacologyRestraint stressPlant Extractsbusiness.industryMaternal DeprivationGastric accommodationPlasma levelsGhrelinRatsDisease Models AnimalchemistryComplementary and alternative medicineMolecular MedicineFemaleGhrelinAnalysis of varianceRestraint stressCorticosteroneGastrointestinal MotilitybusinessStress PsychologicalHormonePhytomedicine
researchProduct

Role of central oxytocin in the inhibition by endotoxin of distension-stimulated gastric acid secretion

2000

The gastric acid hyposecretory state associated with endotoxemia is mediated by a nervous reflex involving the central nervous system. The aim of the present study was to analyse the central effects of different peptides on distension-stimulated gastric acid secretion and the endogenous role of such peptides on the hyposecretory effects of endotoxin. The effect of an intracisternal (i.c.) administration of oxytocin, vasopressin, corticotropin releasing factor (CRF), bombesin, somatostatin and the opioid receptor agonist BW443C or an intravenous (i.v.) injection of a small dose of endotoxin on distension-stimulated gastric acid secretion was studied in the continuously perfused stomach of an…

MaleVasopressinendotoxinCorticotropin-Releasing HormonevasopressinNarcotic AntagonistsGastric DilatationOxytocinchemistry.chemical_compoundVasoconstrictor AgentsReceptorChemistryStomachBombesincorticotropin-releasing factorGeneral MedicineSomatostatinmedicine.anatomical_structurebombesinReceptors Oxytocingastric acid secretionBombesinFemaleSomatostatingastric distensionOligopeptidesAntidiuretic Hormone Receptor Antagonistshormones hormone substitutes and hormone antagonistsmedicine.drugmedicine.medical_specialtyVasopressinsReceptors Corticotropin-Releasing HormoneGastric AcidAdrenergic AgentsInternal medicineoxytocinmedicineAnimalsRats WistarInjections IntraventricularPharmacologyDose-Response Relationship Drugcentral nervous systemOxytocin receptorEndotoxemiaHormonesRatsEndotoxinsReceptors BombesinEndocrinologyOxytocinGastric MucosaGastric acid
researchProduct

Selective bilateral blood sampling from the inferior petrosal sinus in Cushing's disease: effects of corticotropin-releasing factor and thyrotropin-r…

1993

We sought to enhance the sensitivity of selective bilateral blood sampling to determine adrenocorticotropin (ACTH) and prolactin levels in the inferior petrosal sinus (IPS) by administering two stimulatory agents--corticotropin-releasing factor (CRF) and thyrotropin-releasing hormone (TRH). We then determined the ACTH and prolactin levels in the IPS of 10 patients with Cushing's disease. After peripheral administration of both CRF and TRH, ACTH levels were significantly higher on the tumor side in all patients. The prolactin level was significantly higher on the tumor side when CRF or TRH was used to stimulate pituitary secretion. Postsurgical immunohistochemistry studies revealed productio…

Maleendocrine systemPituitary glandmedicine.medical_specialtyCorticotropin-Releasing HormoneThyrotropin-releasing hormonePituitary neoplasmPetrosal Sinus SamplingSensitivity and SpecificityCushing syndromeAdrenocorticotropic HormonePituitary Gland AnteriorInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingPituitary NeoplasmsCushing SyndromeThyrotropin-Releasing Hormonebusiness.industryInferior petrosal sinusCushing's diseasemedicine.diseaseProlactinProlactinmedicine.anatomical_structureEndocrinologyFemaleCardiology and Cardiovascular Medicinebusinesshormones hormone substitutes and hormone antagonistsBlood samplingCardiovascular and interventional radiology
researchProduct

Ethanol Modulates Corticotropin Releasing Hormone Release From the Rat Hypothalamus: Does Acetaldehyde Play a Role?

2010

BACKGROUND AND METHODS Ethanol (EtOH) activates hypothalamic-pituitary-adrenal (HPA) axis, resulting in adrenocorticotropin hormone, glucocorticoid release, and in modifications of the response of the axis to other stressors. The initial site of EtOH action within the HPA system seems to be the hypothalamus. Thus, to determine the mechanisms responsible for these effects, we investigated: (i) whether EtOH was able to release corticotrophic releasing hormone (CRH) from incubated hypothalamic explants; (ii) whether acetaldehyde (ACD), its first metabolite formed in the brain by catalase activity, might play a role in EtOH activity. To this aim, rat hypothalamic explants were incubated with: (…

Maleendocrine systemmedicine.medical_specialtySettore BIO/14 - FARMACOLOGIACorticotropin-Releasing HormoneHypothalamusMedicine (miscellaneous)AcetaldehydeIn Vitro TechniquesToxicologychemistry.chemical_compoundCorticotropin-releasing hormoneInternal medicinemental disordersmedicineAnimalsRats Wistarreproductive and urinary physiologyEthanolbiologyEthanolAcetaldehydeRatsPsychiatry and Mental healthEndocrinologyMechanism of actionchemistryEthanol Acetaldehyde Hypothalamic CRH Release 3-Amino-124-triazole d-Penicillamine.CatalaseHypothalamusCRHbiology.proteinLiberationmedicine.symptomhormones hormone substitutes and hormone antagonistsGlucocorticoidmedicine.drug
researchProduct

Pavlovian conditioning of corticotropin-releasing factor-induced increase of blood pressure and corticosterone secretion in the rat

1992

Corticotropin-releasing factor (CRF) is clearly involved in the central regulation of the pituitary-adrenal axis and, moreover, of autonomic nervous system functions. Enhanced sympathetic activity with subsequent increases in blood pressure and heart rate and attenuation of the baroreceptor reflex results from the intracerebroventricular (i.c.v.) administration of CRF. Additionally, the peptide has a variety of potent effects on behavioural responses in animals similar to those observed after an experimentally evoked stress. It was therefore of obvious interest to examine whether CRF is a possible mediator of the learning processes associated with physiological stress reaction patterns. Thi…

Malemedicine.medical_specialtySympathetic Nervous SystemBaroreceptorCorticotropin-Releasing HormonePhysiologyConditioning ClassicalPituitary-Adrenal SystemHemodynamicsBlood Pressurechemistry.chemical_compoundStress PhysiologicalCorticosteroneInternal medicineHeart ratemedicineAnimalsEndocrine systemInjections Intraventricularbusiness.industryClassical conditioningRats Inbred StrainsRatsAutonomic nervous systemEndocrinologyBlood pressurechemistryCorticosteronebusinesshormones hormone substitutes and hormone antagonistsActa Physiologica Scandinavica
researchProduct

Episodic Social Stress-Escalated Cocaine Self-Administration: Role of Phasic and Tonic Corticotropin Releasing Factor in the Anterior and Posterior V…

2016

Intermittent social defeat stress escalates later cocaine self-administration. Reward and stress both activate ventral tegmental area (VTA) dopamine neurons, increasing downstream extracellular dopamine concentration in the medial prefrontal cortex and nucleus accumbens. The stress neuropeptide corticotropin releasing factor (CRF) and its receptors (CRF-R1, CRF-R2) are located in the VTA and influence dopaminergic activity. These experiments explore how CRF release and the activation of its receptors within the VTA both during and after stress influence later cocaine self-administration in rats.In vivomicrodialysis of CRF in the VTA demonstrated that CRF is phasically released in the poster…

Malemedicine.medical_specialtyendocrine systemCorticotropin-Releasing HormoneMicrodialysisDrug-Seeking BehaviorNeuropeptideSelf AdministrationNucleus accumbensSocial EnvironmentReceptors Corticotropin-Releasing HormoneSocial defeat03 medical and health sciencesCorticotropin-releasing hormoneCocaine-Related Disorders0302 clinical medicineDopamineInternal medicinemental disordersmedicineAnimalsRats Long-EvansSocial stressGeneral Neurosciencemusculoskeletal neural and ocular physiologyDopaminergicVentral Tegmental AreaArticles030227 psychiatryRatsSubstance Withdrawal SyndromeVentral tegmental areamedicine.anatomical_structureEndocrinologynervous systemPsychologyNeuroscience030217 neurology & neurosurgeryhormones hormone substitutes and hormone antagonistsStress Psychologicalmedicine.drug
researchProduct

Antagonism of corticotropin-releasing factor CRF 1 receptors blocks the enhanced response to cocaine after social stress

2018

Numerous studies have shown that social defeat stress induces an increase in the rewarding effects of cocaine. In this study we have investigated the role played by the main hypothalamic stress hormone, corticotropin-releasing factor (CRF), in the effects that repeated social defeat (RSD) induces in the conditioned rewarding effects and locomotor sensitization induced by cocaine. A total of 220 OF1 mice were divided into experimental groups according to the treatment received before each social defeat: saline, 5 or 10 mg/kg of the nonpeptidic corticotropin-releasing factor CRF1 receptor antagonist CP-154,526, or 15 or 30 µg/kg of the peptidic corticotropin-releasing factor CRF2 receptor ant…

PharmacologySocial stressbusiness.industrymedicine.drug_classAntagonistPharmacologyReceptor antagonistConditioned place preference030227 psychiatryCorticotropin-releasing hormone receptor 1Social defeat03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureAnxiogenicmedicinebusiness030217 neurology & neurosurgerySensitizationEuropean Journal of Pharmacology
researchProduct

Safety and side effects of human and ovine corticotropin-releasing hormone administration in man.

1991

Synthetic human and ovine corticotropin-releasing hormone (hCRH, oCRH) are commonly used as a diagnostic tool of the hypothalamo-pituitary-adrenal axis. In this paper reports about side effects after various modes of CRH-application are analyzed and compared to our corresponding data of human studies with hCRH and oCRH. Generally, CRH is well tolerated after single administration and interval-application of standard doses, although minor side effects appear sometimes after higher doses (greater than 200 micrograms hCRH, oCRH) of CRH-bolus-injections. Predominantly the cardiovascular system (e.g. tachycardia, hypotension, flushing) is affected; neuropsychological symptoms are only seen spora…

TachycardiaSingle administrationmedicine.medical_specialtyContinuous infusionCorticotropin-Releasing HormoneDizzinessCorticotropin-releasing hormoneBiological ClocksRisk FactorsInternal medicineTachycardiaDrug DiscoverymedicineFlushingAnimalsHumansIn patientDrug InteractionsGenetics (clinical)SheepHuman studiesDose-Response Relationship Drugbusiness.industryRespirationHead injuryGeneral Medicinemedicine.diseaseHormonesEndocrinologyAnesthesiaMolecular Medicinemedicine.symptombusinessHormoneKlinische Wochenschrift
researchProduct

Modulators of Endogenous Neuroprotection: Estrogen, Corticotropin-releasing Hormone and Endocannabinoids

2005

Age-associated neurodegenerative disorders are among the most challenging problems of our aging society. Alzheimer’s disease is affecting people with increasing frequency, since there is a clear relationship between the incidence of this detrimental disorder and age. Other neurodegenerative disorders, including Parkinson’s disease, stroke and amyotrophic lateral sclerosis, are also frequently observed in our aging society. For most of these diseases, no causal therapy has yet been identified. Many of the treatments given to patients that are affected by these disorders have different side effects, and therefore the search is on to identify novel molecular approaches that may lead to a more …

business.industrymedicine.drug_classCentral nervous systemEstrogen receptorDiseaseNeuroprotectionEndocannabinoid systemCorticotropin-releasing hormonemedicine.anatomical_structureEstrogenmedicinebusinessCAMP response element bindingNeuroscience
researchProduct